Ines Garcia-Suarez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023).

Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023).

Journal: Open forum infectious diseases

Published: March 13, 2026

Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression.

Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression.

Journal: HIV medicine

Published: January 27, 2026

Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain.

Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain.

Journal: HIV medicine

Published: November 05, 2025

Pregnancy in Women with HIV: Incidence and Outcomes over 19 Years in a Multi-Center Cohort in Spain.

Pregnancy in Women with HIV: Incidence and Outcomes over 19 Years in a Multi-Center Cohort in Spain.

Journal: AIDS patient care and STDs

Published: October 15, 2025

Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment.

Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment.

Journal: Open forum infectious diseases

Published: September 18, 2025

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.

Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort.

Journal: HIV medicine

Published: August 20, 2025

Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV.

Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: April 07, 2025

Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time.

Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time.

Journal: HIV medicine

Published: September 25, 2024

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

Journal: The Journal of antimicrobial chemotherapy

Published: July 25, 2024

Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain.

Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain.

Journal: HIV medicine

Published: July 09, 2024

Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.

Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.

Journal: AIDS patient care and STDs

Published: June 25, 2024

Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study.

Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study.

Journal: Journal of clinical medicine

Published: August 28, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026